Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 1/20 | 0.34 |
| ▸ | ITGAV | P06756 | 1/20 | 0.34 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.32 |
| ▸ | KDM1A | O60341 | 2/20 | 0.32 |
| ▸ | IDO1 | P14902 | 1/20 | 0.32 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.31 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.31 |
| ▸ | PIM1 | P11309 | 1/20 | 0.31 |
| ▸ | CDK2 | P24941 | 1/20 | 0.31 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8416556 | 0.85 | ITGB3 (0.34) | ITGB3ITGAVPBRM1KDM1AIDO1 | |
| SCHEMBL8377758 | 0.79 | ITGB3 (0.33) | ITGB3ITGAVPBRM1KDM1AIDO1 | |
| SCHEMBL7242129 | 0.77 | PBRM1 (0.44) | PBRM1 | |
| SCHEMBL7916930 | 0.74 | KIF11 (0.33) | KDM1A | |
| SCHEMBL102501 | 0.73 | ALDH1A1 (0.50) | ITGB3ITGAVPBRM1 | |
| SCHEMBL102502 | 0.73 | ALDH1A1 (0.50) | ITGB3ITGAVPBRM1 | |
| SCHEMBL7247212 | 0.71 | RAF1 (0.35) | CSNK2A1 | |
| SCHEMBL24456032 | 0.69 | DPP4 (0.54) | — | |
| SCHEMBL21956736 | 0.69 | ALDH1A1 (0.52) | — | |
| SCHEMBL8376594 | 0.69 | KDM1A (0.34) | KDM1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030078437-A1 | Novel benzamidoxime derivatives, intermediates and process for their preparation, and their use as fungicides | EICKEN KARL (DE) | 2003-04-24 | — | — | US | disclosed |
| US-6417398-B1 | Benzamidoxim derivatives, intermediate products and methods for preparing them, and their use as fungicides | BASF AKTIENGESELLSCHAFT (DE) | 2002-07-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030078437-A1 | Novel benzamidoxime derivatives, intermediates and process for their preparation, and their use as fungicides | CBR1, CYP1B1, CYP2E1 | ITGB3 2213/4885ITGAV 4279/4885PBRM1 154/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.